Lupus anticoagulant hypoprothrombinemia syndrome associated with bilateral adrenal haemorrhage in a child: early diagnosis and intervention.

Adrenal haemorrhage Adrenal insufficiency Hypoprothrombinemia Lupus anticoagulant Lupus anticoagulant hypoprothrombinemia syndrome

Journal

Thrombosis journal
ISSN: 1477-9560
Titre abrégé: Thromb J
Pays: England
ID NLM: 101170542

Informations de publication

Date de publication:
17 Mar 2021
Historique:
received: 01 09 2020
accepted: 09 03 2021
entrez: 18 3 2021
pubmed: 19 3 2021
medline: 19 3 2021
Statut: epublish

Résumé

Lupus anticoagulant-hypoprothrombinemia syndrome (LAHPS) is characterized by bleeding and thrombosis in patients with autoimmune diseases or infections. Paediatric LAHPS exhibits various degrees of bleeding, ranging from mild to severe; however, adrenal haemorrhage due to LAHPS and its long-term clinical course have not been sufficiently described. A 9-year-old boy presented with prolonged abdominal pain and abnormal coagulation screening tests. The laboratory tests showed prolonged activated partial thromboplastin time and subsequently revealed the presence of lupus anticoagulant, anti-nuclear antibodies, and hypoprothrombinemia, leading to diagnosis of LAHPS. An enhanced computed tomogram demonstrated nodular lesions in the adrenal glands bilaterally, suggestive of adrenal haemorrhage. Laboratory and clinical manifestations exhibited life-threatening adrenal insufficiency that required hydrocortisone administration. The patient developed systemic lupus erythematosus, diagnosed 12 months later. This patient with LAHPS developed rare adrenal failure due to adrenal haemorrhage, a life-threatening event that should be recognized and treated early. In our case, renal dysfunction was also observed when systemic lupus erythematosus was diagnosed 1 year after LAHPS. Our case emphasizes that early recognition of adrenal failure and careful long-term observation is required in patients with autoantibodies.

Sections du résumé

BACKGROUND BACKGROUND
Lupus anticoagulant-hypoprothrombinemia syndrome (LAHPS) is characterized by bleeding and thrombosis in patients with autoimmune diseases or infections. Paediatric LAHPS exhibits various degrees of bleeding, ranging from mild to severe; however, adrenal haemorrhage due to LAHPS and its long-term clinical course have not been sufficiently described.
CASE PRESENTATION METHODS
A 9-year-old boy presented with prolonged abdominal pain and abnormal coagulation screening tests. The laboratory tests showed prolonged activated partial thromboplastin time and subsequently revealed the presence of lupus anticoagulant, anti-nuclear antibodies, and hypoprothrombinemia, leading to diagnosis of LAHPS. An enhanced computed tomogram demonstrated nodular lesions in the adrenal glands bilaterally, suggestive of adrenal haemorrhage. Laboratory and clinical manifestations exhibited life-threatening adrenal insufficiency that required hydrocortisone administration. The patient developed systemic lupus erythematosus, diagnosed 12 months later.
CONCLUSIONS CONCLUSIONS
This patient with LAHPS developed rare adrenal failure due to adrenal haemorrhage, a life-threatening event that should be recognized and treated early. In our case, renal dysfunction was also observed when systemic lupus erythematosus was diagnosed 1 year after LAHPS. Our case emphasizes that early recognition of adrenal failure and careful long-term observation is required in patients with autoantibodies.

Identifiants

pubmed: 33731125
doi: 10.1186/s12959-021-00271-0
pii: 10.1186/s12959-021-00271-0
pmc: PMC7968225
doi:

Types de publication

Journal Article

Langues

eng

Pagination

19

Références

Case Rep Pathol. 2017;2017:1936282
pubmed: 28536665
Lupus. 2015 Jun;24(7):736-45
pubmed: 25391540
J Autoimmun. 2017 Sep;83:95-112
pubmed: 28739356
Thromb J. 2005 Apr 18;3(1):6
pubmed: 15836793
J Thromb Haemost. 2009 Oct;7(10):1737-40
pubmed: 19624461
Hamostaseologie. 2020 Aug;40(3):301-310
pubmed: 32726825
Arthritis Rheum. 2012 Aug;64(8):2677-86
pubmed: 22553077
Int J Hematol. 2017 Feb;105(2):174-183
pubmed: 27730530
Saudi Med J. 2018 Aug;39(8):829-833
pubmed: 30106422
Expert Rev Clin Immunol. 2019 Jan;15(1):73-81
pubmed: 30381978
Int J Hematol. 2019 Aug;110(2):197-204
pubmed: 31165409
Blood. 1983 Apr;61(4):684-92
pubmed: 6403077
Lupus. 2010 Nov;19(13):1520-6
pubmed: 20685773
Medicine (Baltimore). 2012 Sep;91(5):251-260
pubmed: 22932789
Rheumatol Int. 2018 Oct;38(10):1933-1940
pubmed: 30099593
J Clin Endocrinol Metab. 2013 Aug;98(8):3179-89
pubmed: 23783099

Auteurs

Atsushi Sakamoto (A)

Center for Postgraduate Education and Training, National Center for Child Health and Development, NCCHD, Tokyo, Japan. sakamoto-a@ncchd.go.jp.
Children's Cancer Center, National Center for Child Health and Development, Setagaya-ku, Tokyo, 157-8535, Japan. sakamoto-a@ncchd.go.jp.

Masao Ogura (M)

Division of Nephrology and Rheumatology, NCCHD, Tokyo, Japan.

Atsushi Hattori (A)

Division of Endocrinology and Metabolism, NCCHD, Tokyo, Japan.

Kinji Tada (K)

Center for Postgraduate Education and Training, National Center for Child Health and Development, NCCHD, Tokyo, Japan.

Reiko Horikawa (R)

Division of Endocrinology and Metabolism, NCCHD, Tokyo, Japan.

Hisaya Nakadate (H)

Division of Hematology, NCCHD, Tokyo, Japan.

Kimikazu Matsumoto (K)

Children's Cancer Center, National Center for Child Health and Development, Setagaya-ku, Tokyo, 157-8535, Japan.

Keiji Nogami (K)

Department of Pediatrics, Nara Medical University, Kashihara, Nara, Japan.

Masahiro Ieko (M)

Department of Internal Medicine, School of Dentistry, Health Sciences University of Hokkaido, Ishikari-Tobetsu, Hokkaido, Japan.

Akira Ishiguro (A)

Center for Postgraduate Education and Training, National Center for Child Health and Development, NCCHD, Tokyo, Japan.
Division of Hematology, NCCHD, Tokyo, Japan.

Classifications MeSH